149 related articles for article (PubMed ID: 35497433)
1. Upregulation of lncRNA SUMO1P3 promotes proliferation, invasion and drug resistance in gastric cancer through interacting with the CNBP protein.
Guo Y; Wang Y; Ma Y; Chen G; Yue P; Li Y
RSC Adv; 2020 Feb; 10(10):6006-6016. PubMed ID: 35497433
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA SUMO1P3 promotes tumour progression by regulating cell proliferation and invasion in glioma.
Deng D; Mo Y; Xue L; Shao N; Cao J
Exp Ther Med; 2021 May; 21(5):491. PubMed ID: 33791000
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SUMO1P3 drives colon cancer growth, metastasis and angiogenesis.
Zhang LM; Wang P; Liu XM; Zhang YJ
Am J Transl Res; 2017; 9(12):5461-5472. PubMed ID: 29312498
[TBL] [Abstract][Full Text] [Related]
4. LncRNA SUMO1P3 regulates the invasion, migration and cell cycle of gastric cancer cells through Wnt/β-catenin signaling pathway.
Xu Z; Ran J; Gong K; Hou Y; Li J; Guo Y
J Recept Signal Transduct Res; 2021 Dec; 41(6):574-581. PubMed ID: 33179980
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhan Y; Liu Y; Wang C; Lin J; Chen M; Chen X; Zhuang C; Liu L; Xu W; Zhou Q; Sun X; Zhang Q; Zhao G; Huang W
Oncotarget; 2016 Mar; 7(13):16038-48. PubMed ID: 26799188
[TBL] [Abstract][Full Text] [Related]
6. Expression of concern: Upregulation of lncRNA SUMO1P3 promotes proliferation, invasion and drug resistance in gastric cancer through interacting with the CNBP protein.
Fisher L
RSC Adv; 2022 Feb; 12(8):4572. PubMed ID: 35427101
[TBL] [Abstract][Full Text] [Related]
7. The long non-coding RNA SUMO1P3 facilitates breast cancer progression by negatively regulating miR-320a.
Liu J; Song Z; Feng C; Lu Y; Zhou Y; Lin Y; Dong C
Am J Transl Res; 2017; 9(12):5594-5602. PubMed ID: 29312511
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SUMO1P3 acts as a prognostic biomarker and promotes hepatocellular carcinoma growth and metastasis.
Hu S; Liu J; Feng S; Wang Y; Liu H
Aging (Albany NY); 2021 Apr; 13(9):12479-12492. PubMed ID: 33902004
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA SUMO1P3 may promote cell proliferation, migration, and invasion of pancreatic cancer via EMT signaling pathway.
Tian C; Jin Y; Shi S
Oncol Lett; 2018 Nov; 16(5):6109-6115. PubMed ID: 30333879
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
Na-Er A; Xu YY; Liu YH; Gan YJ
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association.
Mei D; Song H; Wang K; Lou Y; Sun W; Liu Z; Ding X; Guo J
Med Oncol; 2013 Dec; 30(4):709. PubMed ID: 23996296
[TBL] [Abstract][Full Text] [Related]
12. SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer.
Zhang Y; Li Y; Han L; Zhang P; Sun S
Biomed Pharmacother; 2019 May; 113():108686. PubMed ID: 30851548
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA SUMO1P3 promotes glioma progression via the Wnt/β-catenin pathway.
Lou JY; Luo J; Yang SC; Ding GF; Liao W; Zhou RX; Qiu CZ; Chen JM
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9571-9580. PubMed ID: 33015800
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of SUMO1P3 represses tumor growth and invasion and enhances radiosensitivity in hepatocellular carcinoma.
Zhou Y; He P; Xie X; Sun C
Mol Cell Biochem; 2019 Jan; 450(1-2):125-134. PubMed ID: 29905911
[TBL] [Abstract][Full Text] [Related]
15. The long noncoding RNA SUMO1P3 as urinary biomarker for monitoring bladder cancer progression.
Galbiati S; Bettiga A; Colciago G; Senti C; Trevisani F; Villa G; Marzinotto I; Ghidini M; Passalacqua R; Montorsi F; Salonia A; Vago R
Front Oncol; 2024; 14():1325157. PubMed ID: 38846969
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SUMO1P3 promotes proliferation and inhibits apoptosis in colorectal cancer by epigenetically silencing CPEB3.
Lin H; Guo Q; Lu S; Chen J; Li X; Gong M; Tang L; Wen J
Biochem Biophys Res Commun; 2019 Apr; 511(2):239-245. PubMed ID: 30799082
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-specific protease 15 contributes to gastric cancer progression by regulating the Wnt/β-catenin signaling pathway.
Zhong M; Zhou L; Fang Z; Yao YY; Zou JP; Xiong JP; Xiang XJ; Deng J
World J Gastroenterol; 2021 Jul; 27(26):4221-4235. PubMed ID: 34326621
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA SUMO1P3 promotes hepatocellular carcinoma progression through activating Wnt/β-catenin signalling pathway by targeting miR-320a.
Wu S; Chen S; Lin N; Yang J
J Cell Mol Med; 2020 Mar; 24(5):3108-3116. PubMed ID: 31970876
[TBL] [Abstract][Full Text] [Related]
19. Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma.
Su X; Wan Y; Xie L; Lin X; Zhao H; Ju X; Fang A
Med Sci Monit; 2019 Sep; 25():6691-6701. PubMed ID: 31489957
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis.
Deng P; Sun M; Zhao WY; Hou B; Li K; Zhang T; Gu F
World J Gastroenterol; 2021 Feb; 27(6):487-500. PubMed ID: 33642823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
